|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Consolidated net income (loss) | |||||
| Total income from discontinued operations | |||||
| Adjustments to reconcile income (loss) from continuing operations to cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment charges | |||||
| Gain on sale of property, plant, and equipment | |||||
| Gain on equity method investments | |||||
| Pension settlement (gain) charges | |||||
| Deferred income taxes | |||||
| Amortization of deferred financing costs | |||||
| Share-based compensation | |||||
| Loss on divestiture | |||||
| Trade receivables and receivables from long-term manufacturing contracts | |||||
| Inventories, net | |||||
| Prepaid expenses and other current assets | |||||
| Trade accounts payable | |||||
| Liabilities from long-term manufacturing contracts and advances, accrued compensation, and other current liabilities | |||||
| Income taxes payable | |||||
| Accrued pension and postretirement | |||||
| Other, net | |||||
| Net cash provided by operating activities from continuing operations | |||||
| Investing activities from continuing operations | |||||
| Capital expenditures | |||||
| Proceeds from sales of property, plant, and equipment | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Proceeds from sale of equity method investment | |||||
| Proceeds from divestiture, net of cash divested | |||||
| Cross-currency swap settlement | |||||
| Proceeds from Sale and Collection of Receivables | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities from continuing operations | |||||
| Financing activities from continuing operations | |||||
| Proceeds from long-term debt, net of discount | |||||
| Repayments of long-term debt | |||||
| Proceeds from revolving credit facilities | |||||
| Repayments on revolving credit facilities | |||||
| Payment of deferred financing costs | |||||
| Payment of dividends on common stock | |||||
| Repurchases of common stock | |||||
| Proceeds from stock option exercises and other | |||||
| Payments for employee taxes on net settlement equity awards | |||||
| Other, net | |||||
| Net cash (used in) provided by financing activities from continuing operations | |||||
| Cash (used in) provided by continuing operations | |||||
| Cash Provided by (Used in) Discontinued Operation | |||||
| Cash Provided by (Used in) Operating Activity, Discontinued Operation | |||||
| Cash Provided by (Used in) Investing Activity, Discontinued Operation | |||||
| Total cash used in discontinued operations | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation, Total | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| At Beginning of Period | |||||
| At End of Period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents held for sale | |||||
Loading...